Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
20 earlier
Greater flexibility for people with systemic lupus erythematosus
Original title: “Saphnelo approved in the US for subcutaneous self‑administration”
Tolebrutinib, which the FDA recently turned back due to safety concerns, received a positive recommendation that positions the therapy for its first regulatory approval.
Original title: “Sanofi MS drug rejected in US gets an endorsement in Europe”
Five new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended five medicines for approval at its April 2026 meeting.The committee recommended…, CHMP statistics Key figures from the April 2026 CHMP meeting are represented in the graphic below. , CHMP statistics Key figures from the April 2026 CHMP meeting are represented in the graphic below…, Positive recommendations on new medicines, Cenrifki INN tolebrutinib Marketing authorisation
Original title: “Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 April 2026”
EMA has recommended granting a marketing authorisation in the European Union (EU) for Redemplo (plozasiran) to treat adults with familial chylomicronaemia syndrome (FCS).FCS is…
Original title: “New medicine to reduce triglycerides in adults with familial chylomicronaemia syndrome”
EMA's office is closed for King's Day in the Netherlands on 27 April and for Labour Day on 1 May 2026.Outside of working hours and on public holidays, it is…
Original title: “EMA business hours over King's Day and Labour Day, 27 April and 1 May”